PALXOTCSemiconductors & Related DevicesFiscal year ends December 31
Palomino Laboratories Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$14.00−0.32 (-2.23%)
Close on Oct 15, 2026
- Market cap
- $305.46M
- P/E (TTM)
- –
- Dividend yield
- –
Palomino Laboratories Inc. cash flow statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -78.3%
Financial strength
- Current ratio
- 53.12
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 5271.2%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 14.85
- Dividend yield
- –